title: Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire.
abstract: BACKGROUND
  Quality-of-life instruments that measure specific functional consequences of mucositis are needed to assess the efficacy of therapeutic interventions targeted against mucositis and to guide patient care. The authors undertook a prospective, multicenter, observational study to assess the validity, reliability, and feasibility of a new instrument, the Oral Mucositis Weekly Questionnaire-Head and Neck Cancer (OMWQ-HN). The OMWQ-HN is a patient-reported outcome questionnaire that measures the symptoms of mucositis, including mouth and throat soreness (MTS), and their impact on patient well-being and function.
  
  
  METHODS
  The OMWQ-HN, along with the Functional Assessment of Cancer Therapy-Head and Neck (FACT-HN), was administered 5 times over an approximately 6-week period to patients with head and neck cancer (HNC) who were receiving radiation therapy with or without chemotherapy. Information on supportive care measures also was collected.
  
  
  RESULTS
  Seventy-five patients were enrolled and completed 93% of scheduled assessments (100% at baseline). The OMWQ-HN demonstrated good test-retest reliability (correlation coefficient, 0.80-0.89). Cross-sectional analyses to assess validity showed that OMWQ-HN scores were different across levels of pain, with those in the worst pain category reporting the highest OMWQ-HN scores. Strong correlations were observed between OMWQ-HN and FACT-HN. Patients experienced increases in MTS, which corresponded with a steady decline in function. MTS scores were highest in the patients who were taking opioid analgesics, suggesting that mucositis pain continued despite standard pain therapy.
  
  
  CONCLUSIONS
  The current results indicated that the OMWQ-HN is a valid, reliable, and feasible instrument for assessing the impact of mucositis on patients who are receiving radiation therapy with or without chemotherapy for HNC.
authors: Department of Oral Medicine and Diagnostic Sciences, College of Dentistry and Chicago Cancer Center, University of Illinois, Chicago, Illinois 60612, USA. jepstein@uic.edu
authors: Joel B
authors: JB
authors: Epstein
authors: Jennifer L
authors: JL
authors: Beaumont
authors: Clement K
authors: CK
authors: Gwede
authors: Barbara
authors: B
authors: Murphy
authors: Adam S
authors: AS
authors: Garden
authors: Ruby
authors: R
authors: Meredith
authors: Quynh-Thu
authors: QT
authors: Le
authors: David
authors: D
authors: Brizel
authors: John
authors: J
authors: Isitt
authors: David
authors: D
authors: Cella
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects; D003131:Combined Modality Therapy; D005069:Evaluation Studies as Topic; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011788:Quality of Life; D011878:Radiotherapy / Q000009:adverse effects; D015203:Reproducibility of Results; D013280:Stomatitis / Q000209:etiology / Q000523:psychology*; D011795:Surveys and Questionnaires
chemical_list: D000970:Antineoplastic Agents